282
70. Swaminathan S, Vavia PR, Trotta F et al
(2007) Formulation of beta-cyclodextrin
based nanosponges of itraconazole. J Incl
Phenom Macrocycl Chem 57(1–4):89–94
71. Osmani RAM, Kulkarni PK, Shanmuganathan
S et al (2016) A 32 full factorial design
for development and characterization of a
nanosponge- based intravaginal in situ gelling
system for vulvovaginal candidiasis. RSC Adv
6(23):18737–18750
72. Anandam S, Selvamuthukumar S (2014)
Fabrication of cyclodextrin nanosponges for
quercetin delivery: physicochemical characterization, photostability, and antioxidant
effects. J Mater Sci 49(23):8140–8153
73. Singireddy A, Subramanian S (2016)
Cyclodextrin nanosponges to enhance the
dissolution profile of quercetin by inclusion complex formation. Part Sci Technol
34(4):341–346
74. Sapino S, Carlotti ME, Cavalli R et al (2013)
Photochemical and antioxidant properties of
gamma-oryzanol in beta-cyclodextrin-based
nanosponges. J Incl Phenom Macrocycl
Chem 75(1–2):69–76
75. Kumar S, Trotta F, Rao R (2018)
Encapsulation of Babchi oil in cyclodextrinbased nanosponges: physicochemical characterization, photodegradation, and in vitro
cytotoxicity studies. Pharmaceutics 10(4):169
76. Silva F, Caldera F, Trotta F et al (2019)
Encapsulation of coriander essential oil in
cyclodextrin nanosponges: a new strategy to
promote its use in controlled-release active
packaging. Innovative Food Sci Emerg
Technol 56:102177
77. Ramírez-Ambrosi M, Caldera F, Trotta F et al
(2014) Encapsulation of apple polyphenols in
b-CD nanosponges. J Incl Phenom Macrocycl
Chem 80(1–2):85–92
78. Jang M, Cai L, Udeani GO et al (1997)
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes.
Science 275(5297):218–220
79. Ansari KA, Vavia PR, Cavalli R (2011)
Cyclodextrin-based nanosponges for delivery
of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study. AAPS
PharmSciTech 12(1):279–286
80. Breda SA, Jimenez-Kairuz AF, Manzo
RH et al (2009) Solubility behavior and
biopharmaceutical classification of novel
high-solubility ciprofloxacin and norfloxacin pharmaceutical derivatives. Int J Pharm
371(1–2):106–113
81. Mendes C, Meirelles GC, Barp CG et al
(2018) 9. Cyclodextrin based nanosponge of
norfloxacin intestinal permeation enhancement and improved antibacterial activity.
Carbohydr Polym 195:586–592
82. Diaz JH (2016) Chemical and plant-based
insect repellents: efficacy, safety, and toxicity.
Wilderness Environ Med 27(1):153–163
83. Peila R, Scordino P, Shanko DB et al
(2017) Synthesis and characterization of
β-cyclodextrin nanosponges for N,N-diethylmeta-toluamide complexation and their
application on polyester fabrics. React Funct
Polym 119:87–94
84. Shende P, Deshmukh K, Tanwar YS et al
(2015) Biomimetic estimation of glucose using non-molecular and molecular
imprinted polymer nanosponges. Int J Pharm
494(1):244–248
85. Trotta F, Caldera F, Cavalli R et al (2016)
Molecularly imprinted cyclodextrin nanosponges for the controlled delivery of
L-DOPA: perspectives. Expert Opin Drug
Deliv 13(12):1671–1680
86. Rao M, Bajaj A, Khole I et al (2013) In vitro
and in vivo evaluation of β-cyclodextrin-based
nanosponges of telmisartan. J Incl Phenom
Macrocycl Chem 77(1–4):135–145
87. Hayashi K, Wakino S, Sugano N et al (2007)
Ca2+ channel subtypes and pharmacology in
the kidney. Circ Res 100(3):342–353
88. Shringirishi M, Mahor A, Gupta R et al (2017)
Fabrication and characterization of nifedipine loaded β-cyclodextrin nanosponges: an
in vitro and in vivo evaluation. J Drug Deliv
Sci Technol 41:344–350
89. Rao MR, Bhingole RC (2015) Nanospongebased pediatric-controlled release dry suspension of gabapentin for reconstitution. Drug
Dev Ind Pharm 41(12):2029–2036
90. Tan DX, Manchester LC, Terron MP et al
(2007) One molecule, many derivatives: a
never-ending interaction of melatonin with
reactive oxygen and nitrogen species? J Pineal
Res 1:28–42
91. Mihailiasa M, Caldera F, Li J et al (2016)
Preparation of functionalized cotton fabrics
by means of melatonin loaded β-cyclodextrin
nanosponges. Carbohydr Polym 142:24–30
92. Kovacs TOG, Lee CQ, Chiu YL et al (2004)
Intravenous and oral lansoprazole are equivalent in suppressing stimulated acid output in
patient volunteers with erosive oesophagitis.
Aliment Pharmacol Ther 20(8):883–889
93. Shende P, Chaphalkar R, Deshmukh K et al
(2016) Physicochemical investigation of engineered nanosuspensions containing model
drug, lansoprazole. J Dispers Sci Technol
37(4):504–511
94. Trotta F, Cavalli R, Martina K et al (2011)
Cyclodextrin nanosponges as effective gas
carriers. J Incl Phenom Macrocycl Chem
1-2(71):189–194
95. Caldera F, Tannous M (2019) Nanosponges
for gas storage. In: Nanosponges: syntheMaria Tannous et al.
70. Swaminathan S, Vavia PR, Trotta F et al
(2007) Formulation of beta-cyclodextrin
based nanosponges of itraconazole. J Incl
Phenom Macrocycl Chem 57(1–4):89–94
71. Osmani RAM, Kulkarni PK, Shanmuganathan
S et al (2016) A 32 full factorial design
for development and characterization of a
nanosponge- based intravaginal in situ gelling
system for vulvovaginal candidiasis. RSC Adv
6(23):18737–18750
72. Anandam S, Selvamuthukumar S (2014)
Fabrication of cyclodextrin nanosponges for
quercetin delivery: physicochemical characterization, photostability, and antioxidant
effects. J Mater Sci 49(23):8140–8153
73. Singireddy A, Subramanian S (2016)
Cyclodextrin nanosponges to enhance the
dissolution profile of quercetin by inclusion complex formation. Part Sci Technol
34(4):341–346
74. Sapino S, Carlotti ME, Cavalli R et al (2013)
Photochemical and antioxidant properties of
gamma-oryzanol in beta-cyclodextrin-based
nanosponges. J Incl Phenom Macrocycl
Chem 75(1–2):69–76
75. Kumar S, Trotta F, Rao R (2018)
Encapsulation of Babchi oil in cyclodextrinbased nanosponges: physicochemical characterization, photodegradation, and in vitro
cytotoxicity studies. Pharmaceutics 10(4):169
76. Silva F, Caldera F, Trotta F et al (2019)
Encapsulation of coriander essential oil in
cyclodextrin nanosponges: a new strategy to
promote its use in controlled-release active
packaging. Innovative Food Sci Emerg
Technol 56:102177
77. Ramírez-Ambrosi M, Caldera F, Trotta F et al
(2014) Encapsulation of apple polyphenols in
b-CD nanosponges. J Incl Phenom Macrocycl
Chem 80(1–2):85–92
78. Jang M, Cai L, Udeani GO et al (1997)
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes.
Science 275(5297):218–220
79. Ansari KA, Vavia PR, Cavalli R (2011)
Cyclodextrin-based nanosponges for delivery
of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study. AAPS
PharmSciTech 12(1):279–286
80. Breda SA, Jimenez-Kairuz AF, Manzo
RH et al (2009) Solubility behavior and
biopharmaceutical classification of novel
high-solubility ciprofloxacin and norfloxacin pharmaceutical derivatives. Int J Pharm
371(1–2):106–113
81. Mendes C, Meirelles GC, Barp CG et al
(2018) 9. Cyclodextrin based nanosponge of
norfloxacin intestinal permeation enhancement and improved antibacterial activity.
Carbohydr Polym 195:586–592
82. Diaz JH (2016) Chemical and plant-based
insect repellents: efficacy, safety, and toxicity.
Wilderness Environ Med 27(1):153–163
83. Peila R, Scordino P, Shanko DB et al
(2017) Synthesis and characterization of
β-cyclodextrin nanosponges for N,N-diethylmeta-toluamide complexation and their
application on polyester fabrics. React Funct
Polym 119:87–94
84. Shende P, Deshmukh K, Tanwar YS et al
(2015) Biomimetic estimation of glucose using non-molecular and molecular
imprinted polymer nanosponges. Int J Pharm
494(1):244–248
85. Trotta F, Caldera F, Cavalli R et al (2016)
Molecularly imprinted cyclodextrin nanosponges for the controlled delivery of
L-DOPA: perspectives. Expert Opin Drug
Deliv 13(12):1671–1680
86. Rao M, Bajaj A, Khole I et al (2013) In vitro
and in vivo evaluation of β-cyclodextrin-based
nanosponges of telmisartan. J Incl Phenom
Macrocycl Chem 77(1–4):135–145
87. Hayashi K, Wakino S, Sugano N et al (2007)
Ca2+ channel subtypes and pharmacology in
the kidney. Circ Res 100(3):342–353
88. Shringirishi M, Mahor A, Gupta R et al (2017)
Fabrication and characterization of nifedipine loaded β-cyclodextrin nanosponges: an
in vitro and in vivo evaluation. J Drug Deliv
Sci Technol 41:344–350
89. Rao MR, Bhingole RC (2015) Nanospongebased pediatric-controlled release dry suspension of gabapentin for reconstitution. Drug
Dev Ind Pharm 41(12):2029–2036
90. Tan DX, Manchester LC, Terron MP et al
(2007) One molecule, many derivatives: a
never-ending interaction of melatonin with
reactive oxygen and nitrogen species? J Pineal
Res 1:28–42
91. Mihailiasa M, Caldera F, Li J et al (2016)
Preparation of functionalized cotton fabrics
by means of melatonin loaded β-cyclodextrin
nanosponges. Carbohydr Polym 142:24–30
92. Kovacs TOG, Lee CQ, Chiu YL et al (2004)
Intravenous and oral lansoprazole are equivalent in suppressing stimulated acid output in
patient volunteers with erosive oesophagitis.
Aliment Pharmacol Ther 20(8):883–889
93. Shende P, Chaphalkar R, Deshmukh K et al
(2016) Physicochemical investigation of engineered nanosuspensions containing model
drug, lansoprazole. J Dispers Sci Technol
37(4):504–511
94. Trotta F, Cavalli R, Martina K et al (2011)
Cyclodextrin nanosponges as effective gas
carriers. J Incl Phenom Macrocycl Chem
1-2(71):189–194
95. Caldera F, Tannous M (2019) Nanosponges
for gas storage. In: Nanosponges: syntheMaria Tannous et al.